We have shown previously that IGFBP-2 promotes prostate cancer growth in both an IGF-I-dependent and independent manner [17] and that hyperglycaemia induced up-regulation of IGFBP-2 in prostate cancer cells which resulted in resistance to chemotherapy [18]. The gene discussed is IGF1; the disease is prostate carcinoma.